Hemophilia: A High Cost Low Volume Disease: Suitable Preventive Strategies for Developing and Developed Countries

Hemophilia A & B are congenital bleeding disorders affecting 1:10-20,000 population and 1:20 to 40,000 population respectively. Hemophilia represents the prototype of high cost low volume disease. Eighty persons of world hemophilia population lives in financially poor developing countries, where